Michael D. Stein, MD, Professor of Medicine and Community Health at the Warren Alpert Medical School of Brown University, and Director of the Substance Abuse Research Unit (SARU) at Rhode Island Hospital
Jane M. Liebschutz, MD, MPH, FACP; Site Principal Investigator
Debra Herman, PhD; Psychologist and co investigator developed the survey assessment tools
Donna Beers, RN BSN CARN; Opioid Treatment Specialist
Colleen Labelle, RN CARN; Program Director STATE OBOT-B
Daniel Alford, MD; Co-investigator
Alexander Walley, MD; Co-investigator
The goal of this study is to determine ways of reducing HIV risk behaviors in opioid dependent drug users recruited during hospitalization and followed into the community. In the general hospital setting, the prevalence of injection drug use is high, patients who otherwise might not seek care are accessible, and the presence of a drug- related illness can set the stage for patients to be more receptive to interventions (Stein, 1999). In the present study we suggest that initiation of Suboxone (buprenorphine/naloxone ) during hospitalization, and linkage to maintenance Suboxone in office-based practices after hospital discharge will enhance HIV risk reduction among opioid dependent drug users.